Although studies have shown a largely continuous association between Lp(a) and the risk for ASCVD, current international guidelines recommend a clinically relevant threshold for elevated Lp(a) as ≥50 mg/dL (125 nmol/L).5 This evidence concerns the gene LPA and atherosclerosis.